| The Pharmaceutical Journal |
|
News summary |
| Related websites |
Statin head-to-headRosuvastatin (Crestor) decreases low density lipoprotein-cholesterol in patients with hypercholesterolaemia to a greater extent than atorvastatin (Lipitor), a study funded by AstraZeneca shows. Data were presented at the European Society of Cardiology congress in Berlin this week. |
Home | Journals | News | Notice-board | Search | Jobs Classifieds | Site
Map | Contact us
©The Pharmaceutical Journal